For instance, inhibition of DGKα expression via molecular genetics techniques such as the use of small-interfering RNA against DGKα or the use microRNA-297 showed promise as evidenced by the suppression of the proliferation of colon and breast cancer as well as glioblastoma [11,75]. Here, DGKA is linked to breast carcinoma.